Aquaporin Adjusts Revenue Forecast for 2025 Amid Strategic Review Initiatives

Aquaporin A/S, a pioneering company in water technology known for its innovative approaches to water filtration, announced recent updates regarding its financial outlook for the upcoming year. According to a recent press release, Aquaporin is lowering its revenue guidance for 2025, while keeping its EBITDA guidance intact. This revision comes as part of their broader strategy to enhance their operational strength and financial stability.

In its announcement dated August 11, 2025, Aquaporin stated that it has adjusted its revenue forecast to DKK 40-50 million, a decrease from the previously projected DKK 60-80 million. This decision stems from a combination of a lower inflow of orders and specific delays in processing certain orders. Notably, the three areas the company operates in—Residential Drinking Water, Industrial Water, and Forward Osmosis Market Development—are expected to contribute roughly equally to the projected revenue for the year.

Chief Executive Officer Ulrik Lund Jakobsen emphasized the company's resilient foundation, especially concerning its project pipeline. He noted that despite the slower-than-anticipated order materialization, he remains optimistic about the growth pipelines ahead and is eager to explore further advancements during the company's strategic review. This review aims to reinforce the company's balance sheet as they continue their trajectory in the industry.

The strategic review is a proactive measure to identify various avenues for raising capital. Potential strategies include both equity and debt financing segments or forming strategic partnerships and transactions. This completes a comprehensive approach toward not just managing current challenges but also planning for sustained future growth.

The company's estimate for EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which is expected to remain unchanged, indicates a projected loss of DKK 45-55 million. Aquaporin's leadership believes that capitalizing on their core competencies and unique technology will enable them to recover in the latter part of 2025, as has been their historical trend.

Aquaporin’s unique technology—known as Aquaporin Inside®—is grounded in Nobel Prize-winning biological research. It has allowed the company to carve a niche in the global market by addressing urgent water filtration challenges across various industries including industrial wastewater treatment and residential drinking water solutions. This is particularly relevant as global water scarcity becomes an increasingly pressing issue.

As part of its ongoing commitment, Aquaporin continues to innovate and adapt its technology for a range of applications, working with partners across the globe to enhance the quality and accessibility of drinking water. The company will release its Half-Year Interim Report on August 21, 2025, which will provide deeper insight into its financial status and strategic directions.

In summary, while Aquaporin adjusts its revenue expectations, the company's decision to maintain its EBITDA forecast and initiate a strategic review signifies a profound commitment to navigating the complexities of the water technology industry. The leadership believes that by reinforcing its capital framework and exploring new opportunities, Aquaporin is poised to face the future with resilience and innovation, reinforcing its position in addressing global water challenges moving forward.